Monday, August 3, 2020

Serum gets DCGI nod for Phase 2 & 3 trials

India’s apex drug regulator has allowed Pune-based Serum Institute of India to conduct late-stage — Phase 2 and 3 — human trials in India for the Oxford University Covid-19 vaccine candidate.

from Times of India https://timesofindia.indiatimes.com/india/serum-gets-dcgi-nod-for-phase-2-3-trials/articleshow/77340150.cms
Share:

0 comments:

Post a Comment

Blog Archive

Definition List

Unordered List

Support